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A Critical Cell-Intrinsic Role for Serum Response Factor in
Glial Specification in the CNS
Paul P. Y. Lu and Narendrakumar Ramanan
Department of Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri 63110
Astrocytes andoligodendrocytes play crucial roles in nearly every facet of nervous systemdevelopment and function, including neuronal
migration, synaptogenesis, synaptic plasticity, and myelination. Previous studies have widely characterized the signaling pathways
important for astrocyte differentiation and unveiled a number of transcription factors that guide oligodendrocyte differentiation in the
CNS. However, the identities of the transcription factors critical for astrocyte specification in the brain remain unknown. Here we show
that deletion of the stimulus-dependent transcription factor, serum response factor (SRF), in neural precursor cells (NPCs) (Srf–Nestin–
cKO) results in nearly 60% loss in astrocytes and 50% loss in oligodendrocyte precursors at birth. Cultured SRF-deficient NPCs exhibited
normal growth rate and capacity to self-renew. However, SRF-deficient NPCs generated fewer astrocytes and oligodendrocytes in re-
sponse to several lineage-specific differentiation factors. These deficits in glial differentiation were rescued by ectopic expression of
wild-type SRF in SRF-deficient NPCs. Interestingly, ectopic expression of a constitutively active SRF (SRF–VP16) in NPCs augmented
astrocyte differentiation in the presence of pro-astrocytic factors. However, SRF–VP16 expression in NPCs had an inhibitory effect on
oligodendrocyte differentiation. In contrast,mice carrying conditional deletion of SRF in developing forebrain neurons (Srf–NEX–cKO)
did not exhibit any deficits in astrocytes in the brain. Together, our observations suggest that SRF plays a critical cell-autonomous role in
NPCs to regulate astrocyte and oligodendrocyte specification in vivo and in vitro.
Introduction
Astrocytes play multiple critical roles in brain development and
functioning (Barres, 2008), and abnormalities in astrocyte devel-
opment have been implicated in neurological disorders, includ-
ing epilepsy, neurodegenerative disorders, and brain tumors
(Lobsiger andCleveland, 2007;Oberheim et al., 2008). Oligoden-
drocytes are essential for myelination (Hirano, 1968; Emery,
2010), and dysregulated myelination causes multiple sclerosis
and leukodystrophy (Emery, 2010). Elucidating the molecular
mechanisms regulating astrocyte and oligodendrocyte develop-
ment is critical to our understanding of how these mechanisms
might go awry in these disorders.
The onset of astrogliogenesis begins toward the end of neuro-
genesis and is regulated by several ligand–receptor complexes
(Okano and Temple, 2009; Freeman, 2010). Widely studied cy-
tokines among them include ciliary neurotrophic factor (CNTF),
leukemia inhibitory factor (LIF), and cardiotrophin-1 (CT-1),
which activate the Janus kinase (JAK)/signal transducer and ac-
tivator of transcription (STAT) pathway to promote astrocyte
differentiation (Johe et al., 1996; Bonni et al., 1997; Rajan and
McKay, 1998; Barnabe´-Heider et al., 2005). Activation of bone
morphogenetic protein 2/4 (BMP-2/4) signaling results in phos-
phorylation of SMAD (Sma and Mad-related proteins) tran-
scription factors and their association with STAT3 to regulate
expression of astrocyte-specific genes (Nakashima et al., 1999).
However, perturbation of JAK/STAT signaling caused only a 45–
70% reduction in astrocytes in vivo, suggesting contributions
from other pathways. Notch is another widely studied pathway
and gain-of-function studies have shown that Notch receptors
play a permissive role in neural precursor cells (NPCs) to pro-
mote astrocyte differentiation (Morrison et al., 2000; Tanigaki et
al., 2001; Gaiano and Fishell, 2002).
Transcriptional control of astrocyte specification has been
studiedmainly in the spinal cord. Sox9 loss causes deficits in both
astrocyte and oligodendrocyte generation (Stolt et al., 2003),
whereas nuclear factor I-A/B and bHLH transcription factors,
stem cell leukemia, and KLF15 (Kru¨ppel-like factor 15) were
found to be necessary and/or sufficient for astrocyte specification
(Muroyama et al., 2005; Deneen et al., 2006; Fu et al., 2009).
Oligodendrocyte specification occurs at late embryonic and early
postnatal periods (Miller, 1996; Lee et al., 2000). Extracellular
sonic hedgehog (Shh) signal in ventral telencephalon is necessary
and sufficient for inducing commitment to oligodendrocyte pre-
cursors (Alberta et al., 2001; Tekki-Kessaris et al., 2001). Down-
stream to Shh signaling, two bHLH transcription factors, Olig1
and Olig2, are particularly important for oligodendrocyte devel-
opment (Lu et al., 2001, 2002; Zhou et al., 2001; Zhou and An-
derson, 2002). Other transcription factors, including Ying Yang 1
and members of Sox family of transcription factors, including
Sox9, Sox10, and Sox17, play critical roles in oligodendrocyte
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specification (Stolt et al., 2002, 2003; Sohn et al., 2006; He et al.,
2007).
Serum response factor (SRF) is a stimulus-dependent tran-
scription factor required for differentiation and development of
several different cell types, including keratinocytes, cardiac, and
smooth muscle cells (Miano et al., 2004; Parlakian et al., 2004;
Niu et al., 2005; Verdoni et al., 2010). Within the CNS, SRF
regulates axon growth, tangential neuronal migration, activity-
dependent gene expression, synaptic plasticity, and learning and
memory (Ramanan et al., 2005; Etkin et al., 2006; Kno¨ll et al.,
2006; Stern et al., 2009; Johnson et al., 2011; Lu and Ramanan,
2011). Here, we report a previously unidentified role for SRF in
astrocyte and oligodendrocyte differentiation in the brain.
Materials andMethods
Animals. Srf f/f mice (control) were maintained as a homozygous colony
as described previously (Ramanan et al., 2005). The Srf–Nestin–cKOand
Srf–NEX–cKO were generated as described previously (Lu and Ra-
manan, 2011) using a Nestin–Cre transgenic mouse line (Tronche et al.,
1999) and a NEX–Cre line (Goebbels et al., 2006). The Srf f/;NesCre
double-heterozygous mice did not exhibit any discernible phenotype.
Pups of either sex (n 3–5) from at least two different litters were used
in all experiments. All experiments were approved by the Animals Stud-
ies Committee, Division of ComparativeMedicine,WashingtonUniver-
sity School of Medicine (St. Louis, MO).
Immunostaining, cell counts, and statistical analyses. Immunohisto-
chemistry was performed as described previously (Ramanan et al., 2005).
Primary antibodies used included the following: Aldh1L1 (1:100; catalog
#73-140; NeuroMab), S100 (1:1000; Sigma-Aldrich), GFAP (1:1000;
catalog #G145; Sigma-Aldrich), SRF (1:1500; Santa Cruz Biotechnol-
ogy), Nestin (1:200; Developmental Studies Hybridoma Bank), Tuj1/-
tubulin III (1:1000; Sigma-Aldrich), adenomatous polyposis coli (APC)
(1:1000; Millipore), -gal (1:1500; Aves Lab), O4 (1:750; Millipore),
Olig2 (1:1000; Sigma-Aldrich), Olig1 (1:50; NeuroMab), activated-
Caspase 3 (1:1500; Millipore), Sox2 (1:100; Santa Cruz Biotechnology),
and platelet-derived growth factor receptor  (PDGFR) (1:750;
Thermo Fisher Scientific). Secondary antibodies included the following:
anti-goat Cy3 (1:300; Jackson ImmunoResearch), anti-mouse and anti-
rabbit Alexa Fluor-594 and Alexa Fluor-488 (1:500; Invitrogen). Biotin-
ylated anti-rabbit and anti-mouse secondary antibodies (1:500; Vector
Laboratories) were used along with ABC-Elite or VIP staining kits (Vec-
tor Laboratories). Cell count and statistical analyses were performed as
described previously (Lu and Ramanan, 2011).
Western blotting. Total protein, 25 g, prepared from neurospheres was
immunoblotted by standard procedures. Primary antibodies were anti-SRF
(1:5000; Santa Cruz Biotechnology) and anti-tubulin (1:10,000; Sigma-
Aldrich). Secondary antibodies include anti-HRP (1:20,000; anti-mouse;
Jackson ImmunoResearch; and anti-rabbit; Invitrogen). Chemilumines-
cence detection was performed using Immobilon reagent (Millipore).
Neurosphere culture. Neurosphere cultures and culture media were
prepared as described previously (Dasgupta and Gutmann, 2005). Neo-
natal cortices were dissected and trypsinized at 37°C for 15 min. Cells
were mechanically dissociated by pipetting and incubated in 10% fetal
calf serum medium for 10 min and pelleted by centrifugation. Dissocia-
tion medium was used to wash the cells before resuspending in growth
medium containing 5 ng/ml FGF and EGF. Samples were cultured at
250,000–500,000 cells per 60 mm dish at 37°C with 5% CO2 for 4 d.
NPC proliferation analysis. Srf f/f, Srf f/;NesCre, and Srf f/f;NesCre
mice-derived neurospheres were dissociated by trypsin digestion and
seeded at similar cell densities in 24-well plates with fresh growth me-
dium. Every 12 h, neurospheres from triplicate wells were collected and
dissociated, and cell counts were determined. Cell growthwasmonitored
over 84 h, and results were plotted with sample mean and SEM. The
experiment was repeated at least three times using NPCs generated from
animals from different litters.
Secondary neurosphere analysis. NPCs from control and Srf–Nestin–
cKObrains were grown as neurospheres. After 4DIV, neurospheres were
dissociated and seeded as single cells. Approximately 50–70 single NPCs
from each background were plated in 96-well plates and grown in fresh
growthmedium. The number of new neurospheres wasmonitored every
24 h and over 5 d to measure the percentage of cells that gave rise to a
secondary neurosphere. The experiment was repeated twice using ani-
mals from different litters.
NPC differentiation. Neurospheres were trypsinized and washed with
dissociation medium and were plated at 150,000 cells per well in 24-well
plates in differentiation medium (growth medium without FGF and
EGF). To enrich for astrocytes, the following pro-astrocytic growth fac-
tors and cytokines were supplemented either individually or collectively:
CNTF, 100ng/ml (Peprotech); LIF, 40 ng/ml (Millipore); CT-1, 50 ng/ml
(Peprotech); BMP-2, 30 ng/ml (Peprotech); interleukin-6 (IL6), 20
ng/ml (Peprotech); sIL6R, 25 ng/ml (Peprotech); and Jagged-1 (Jag-1),
500 ng/ml (R & D Systems). Cells were fixed using 4% sucrose in 4%
paraformaldehyde in PBS and immunostained 4 d after induction. To
enrich for oligodendrocytes, PDGF at 10 ng/ml (Peprotech) and 3,3,5-
triiodo-L-thyronine (T3) at 30 ng/ml (MP Biomedicals) were added to
NPCs. The percentage of oligodendrocyte precursor cells (OPCs) gener-
ated was analyzed at 2 d after induction, and the percentage of differen-
tiated oligodendrocytes was analyzed at 4 d after induction.
Generation of murine stem cell virus. The retroviral murine stem cell
virus vector (MSCV) was obtained as a gift from Dr. David Gutmann
(Washington University School of Medicine) (Dasgupta and Gutmann,
2005). SRF and a constitutively active variant of SRF (SRF–VP16) were
cloned into the MSCV plasmid. For generating virulent particles,
HEK293T cells were transfected with each of theMSCV constructs along
with complementary T-helper plasmid using Fugene HD (Roche). Cul-
ture supernatant containing the virus particles was collected at 48 and
72 h and filtered through a 0.4 m syringe filter. For viral transduction,
NPCswere trypsinized and grown in amixture of 20% freshNPC growth
medium and 80% viral supernatant for 2 d before switching to 100%
NPC growth medium for an additional 3–4 d. The empty MSCV was
used as a control for analyzing the effects of MSCV–SRF and MSCV–
SRF–VP16 in rescue experiments.
Results
SRF ablation results in reduced astrocyte numbers in vivo
SRF has been shown to regulate cell-fate specification in a cell-
autonomousmanner in several organ systems inmice (Miano et al.,
2004; Parlakian et al., 2004; Sandbo et al., 2009;Verdoni et al., 2010),
but whether SRF has similar roles in the nervous system has re-
mained unexplored. To address this, we conditionally deleted SRF
withinNPCsusing aNestin–Cre transgenicmouse line (Srf–Nestin–
cKO) (Lu and Ramanan, 2011). The Srf–Nestin–cKO mice died
neonatally anddid not exhibit any defects in cell survival, neurogen-
esis, or neuronal subtype specification (Lu and Ramanan, 2011).
Because neurogenesis was unaffected in Srf–Nestin–cKO mice, we
examined astrocytes at P0.5 by immunostaining for the astrocyte
marker GFAP. We found that Srf–Nestin–cKO mice exhibited
nearly 60%reduction in astrocytes inmultiple brain regions, includ-
ing neocortex, hippocampus, corpus callosum, and thalamus (Fig.
1A and data not shown). We next assessed SRF deletion in astro-
cytes. Coimmunostaining for GFAP and SRF revealed that SRF is
robustly expressed in astrocytes of control mice but not in Srf–Nes-
tin–cKOmice (Fig. 1B).We also confirmed that reduced astrocytes
in Srf–Nestin–cKOmice were not attributable to diminishedGFAP
expression. Immunostaining brain sections from Srf–Nestin–cKO
and control mice using two other astrocyte markers, Aldh1L1 (Ca-
hoy et al., 2008) and S100, showed that control mice had signifi-
cantly more astrocytes in several brain regions, including neocortex
and hippocampus, compared with Srf–Nestin–cKO mice (Fig.
1C–F; n 5mice).
Our recent findings revealed that Srf–Nestin–cKO mice did
not exhibit any deficits in neurogenesis or increased apoptosis
during development (Lu and Ramanan, 2011). However, there
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was an increase in proliferative precursor cells in the subventricu-
lar zone in Srf–Nestin–cKO mice (Lu and Ramanan, 2011),
which is possibly a result of impairment in glial lineage commit-
ment. Together, these findings suggest that the decrease in astro-
cytes in neonatal Srf–Nestin– cKO mice reflects a critical
requirement of SRF for astrocyte differentiation in vivo.
SRF deficiency in NPCs impairs astrocyte specification
in vitro
To study the role of SRF in astrocyte specification further, we
used the neurosphere culture system (Dasgupta and Gutmann,
2005). NPCs cultured from P0.5 cortices of control and Srf–
Nestin– cKO brains formed neurospheres within 2–3 d in the
presence of EGF and FGF as mitogens and were physically indis-
tinguishable from one another (Figs. 2A, 3A and data not
shown). Coimmunostaining for the NPCmarker Nestin and SRF
showed that neurospheres from control mice exhibited strong
immunoreactivity for both SRF and Nestin. In contrast, neuro-
spheres from Srf–Nestin–cKO mice were positive for Nestin but
lacked SRF (Fig. 2A). Immunoblotting of total protein isolated
from control and SRF-deficient neurospheres further confirmed
SRF deletion in NPCs from Srf–Nestin–cKO mice (Fig. 2B).
Figure 1. SRF is required for astrocyte specification in vivo. A, Astrocytes were immunostained using anti-GFAP antibodies. Cell count analyses from several brain regions, including neocortex,
hippocampus, striatum, and thalamus, indicate a significant reduction in astrocytes in Srf–Nestin– cKOmice comparedwith control littermates (n 5mice).B, Coimmunofluorescence staining for
SRF and GFAP shows robust SRF staining in astrocytes in control mice but not in Srf–Nestin– cKOmice (n 4mice). Scale bar, 10m (shown here is hippocampus). C, Aldh1L1 immunostaining of
P0.5 brain sections from control and Srf–Nestin– cKOmice shows astrocytes in several brain regions. Scale bar, 50m. D, Quantification of cell counts from C (n 5mice). E, Immunostaining for
S100 astrocytes in control and Srf–Nestin– cKO mutant mice. Scale bar, 50m. F, Quantification of cell counts in D (n 5 mice).
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Likewise, SRF was completely ablated in NPCs isolated from cor-
tices of E12.5 Srf–Nestin–cKO mice (data not shown). We next
analyzed the effect of SRF deletion on NPC proliferation and
found that SRF-deficient and SRF-heterozygous NPCs had rates
of proliferation comparable with NPCs from control mice (Fig.
2C). We analyzed the capacity of SRF-deficient NPCs to self-
renew by assessing their ability to form clonal secondary neuro-
spheres from single NPCs. SRF loss did not affect the capacity of
NPCs to form secondary neurospheres (Fig. 2D). These findings
demonstrate that SRF deletion in NPCs does not affect NPC
growth rate and capacity for self-renewal in vitro.
NPCs are multipotent and are capable of differentiating into
neurons, astrocytes, and oligodendrocytes following mitogen
withdrawal (Rao, 1999; Liu and Rao, 2004; Ahmed, 2009). We
found that SRF-deficient NPCs were capable of generating neu-
rons, astrocytes, and oligodendrocytes as identified by the expres-
sion -tubulin III (TujI) in neurons, GFAP in astrocytes, and
coexpression of APC and O4 in differentiated oligodendrocytes
(Hegedus et al., 2007; Fancy et al., 2011) (Fig. 2E). Similar to that
observed in vivo, SRF-deficient NPCs generated significantly
fewer astrocytes and oligodendrocytes compared with wild-type
NPCs, whereas similar number of neurons was generated (Fig.
2F). These results confirm that SRF is dispensable for neurogen-
esis but is critical for glial specification.
SRF-deficient NPCs fail to respond to pro-astrocytic stimuli
Astrocyte cell fate can be induced by several different extracellular
ligands. We tested the ability of SRF-deficient NPCs to generate
Figure 2. SRF-deficient NPCs exhibit normal proliferation and self-renewal.A, NPCs, identified by Nestin expression, were isolated from forebrains of P0.5 control and Srf–Nestin– cKOmice and
cultured as neurospheres for 4 DIV (top row). Only neurospheres from control mice, but not Srf–Nestin– cKOmice, robustly express SRF (middle row). Bottom row showsmerged image of top and
middle rows along with DAPI. Scale bar, 50m. B, Immunoblotting of total protein from cultured NPCs shows SRF loss in neurospheres from Srf–Nestin– cKO mice. C, Control. C, NPCs from P0.5
control, Srf–Nestin heterozygous, and Srf–Nestin– cKOmice were grown as neurospheres, which were collected at the indicated times, and cell count was determined. SRF-deficient NPCs exhibit
comparable growth rates with that of control and SRF heterozygous cells (n 3). D, NPCs growing as neurospheres were trypsinized, and the number of neurospheres generated from single cells
was determined at the indicated time points. The ability of single SRF-deficient NPCs to form secondary neurospheres was comparable with that of control NPCs (n 2). E, NPCs from control and
Srf–Nestin– cKO mice could generate neurons (Tuj1), astrocytes (GFAP), and differentiated oligodendrocytes (APC/O4) during mitogen withdrawal. Astrocytes and oligodendrocytes
derived fromSRF-deficientNPCs appeared less elaborate than those fromcontrolNPCs. Scale bar, 10m.F, Cell count analyses fromE showa significant decrease in astrocytes andoligodendrocytes,
but not neurons, generated from SRF-deficient NPCs 4 d after induction.
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astrocytes in the presence of these known pro-astrocytic ligands.
After mitogen withdrawal and in the presence of CNTF and LIF,
wild-type NPCs differentiated predominantly into astrocytes at 4
DIV with characteristic stellar morphology along with 0.5%
neurons and oligodendrocytes (Fig. 3A,A,A and data not
shown). In contrast, SRF-deficient NPCs generated significantly
fewer astrocytes compared with wild-type NPCs, and a large pro-
portion of cells remained spherical and precursor cell like (Fig.
Figure 3. SRF-deficient NPCs fail to differentiate in response to pro-astrocyte stimuli. A, NPCs from control and Srf–Nestin–cKO mice were cultured as neurospheres for 4 DIV. The neurospheres were
trypsinized and induced with CNTF (100 ng/ml) and LIF (40 ng/ml) (A, A). SRF-deficient NPCs generated fewer astrocytes compared with wild-type cells as visualized by GFAP immunostaining (A). The
SRF-deficient astrocytes also appeared smaller and less stellar (A). A and A represent independent experiments. B, NPCs from control and Srf–Nestin–cKO mice were induced into astrocytes by several
pro-astrocytic ligandsas indicated.At4dafter induction, SRF-deficientNPCsgenerated significantly fewerastrocytes comparedwithNPCs fromcontrol littermates as visualizedbyGFAP immunolabeling. Scale
bar,25m.C,QuantificationofGFAPastrocytes inB showsthatSRF is critically requiredunderall these inductionconditions forastrocytespecification(n3experiments).D, ControlandSRF-deficientNPCs
were cultured in thepresenceof all ligands shown inB, and cellswere immunostainedat4DIV for astrocytes (GFAPandS100) andNPCs (Sox2). Arrowspoint toS100 cells. Scalebar, 25m.E, Cell count
analyses forD show that loss of SRF impairs commitment to astrocytes even in the presence of several pro-astrocyte signals and thatmore SRF-deficient NPCs remain as Sox2 precursors in culture.
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3A,A). Furthermore, the small population of SRF-deficient cells
that were GFAP positive (GFAP) did not develop elaborate
astrocytic processes and stellate morphology that were exhibited
by wild-type astrocytes.
We also tested the ability of other cytokines and pro-astrocytic
ligands, including CT-1, IL6, BMP-2, and Jag-1 to promote as-
trocyte fate choice (Kahn and De Vellis, 1994; Ma¨rz et al., 1999;
Nakashima et al., 2001; Ochiai et al., 2001; Takizawa et al., 2001;
Yanagisawa et al., 2001; Grandbarbe et al., 2003; Barnabe´-Heider
et al., 2005; Namihira et al., 2009).When cultured in the presence
of each of the above ligands, SRF-deficient NPCs generated sig-
nificantly fewer astrocytes compared with control NPCs (Fig.
3B,C), suggesting that SRF might be broadly required for astro-
cyte specification rather than being necessary for mediating a
particular pro-astrocyte signaling transduction pathway. We
next asked whether these stimuli added together were capable of
overcoming the impairment in astrocyte differentiation exhib-
ited by SRF-deficient NPCs. Immunostaining for anti-GFAP and
anti-S100 at 4-days after induction showed attenuated astrocyte
specification exhibited by SRF-deficient NPCs even in the pres-
ence of multiple pro-astrocytic stimuli (Fig. 3D,E).
Because SRF deletion in NPCs does not lead to an increase
or impairment in neurogenesis but rather a decrease in astro-
cytes and oligodendrocytes, we sought to determine the fate of
NPCs remaining in culture. Immunostaining for Sox2, a tran-
scription factor expressed specifically by NPCs, showed that,
compared with 63% of control cells, 76% of SRF-deficient cells
were Sox2 at 4 d after induction (Fig. 3D,E). This suggests
that, in the absence of SRF, NPCs are less able to respond to
pro-astrocytic signals and consequently, more of them remain
as precursors. Furthermore, we did not observe any significant
increases in the number of precursor cells in these cultures
after astrocyte induction (data not shown), which suggests
that the NPCs are not actively proliferating in the absence of
mitogens (EGF and FGF). Therefore, the decrease in the per-
centage of GFAP cells is not attributable to an increase in the
pool of proliferating SRF-deficient precursor cells. This in-
crease in Sox2 cells in SRF-deficient cultures was similar to
that observed in the brains of P0.5 Srf–Nestin– cKO mice,
which exhibited an increase in p-histone-H3, Ki67, and
Sox2 cells along the subventricular zone and in neocortex
(Lu and Ramanan, 2011).
Figure 4. SRF deletion in neurons does not affect astrocyte differentiation.A, Brain sections fromP0.5 control and Srf–NEX– cKOmicewere immunostained using anti-Aldh1L1 antibody to label
all astrocytes (arrows). Neocortex and hippocampus are shown. Scale bar, 20m.B, Quantification of astrocyte cell count fromA shows no significant difference in astrocytes in Srf–NEX– cKOmice
compared with control littermates (n 3 mice). C, Immunofluorescence staining for GFAP and Aldh1L1 to label astrocytes in 3-month-old control and Srf–NEX– cKO mice. No GFAP astrocytes
were seen in neocortex because GFAP expression in adult brain is restricted to astrocytes in the white matter and hippocampus but not in the neocortex. In contrast, Aldh1L1 labels all astrocytes,
including those in neocortex of both groups of mice. Scale bar, 200m. C represents magnified view of the boxed region. Scale bar, 20m. D, Quantification of Aldh1L1 astrocytes in C shows
no significant difference in neocortex and hippocampus of Srf–NEX– cKOmice and control littermates (n 3 mice).
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SRF is required cell autonomously for astrocyte
differentiation in vivo
Recent observations have shown that newbornneurons and com-
mitted NPCs promote astrocyte specification by secreting Notch
ligands, such as Jag-1, and thus activating Notch signaling in
neighboring uncommitted NPCs (Namihira et al., 2009). Be-
cause SRF is also deleted in neurons in Srf–Nestin– cKO mice,
the deficits in astrocytes could be attributable to non-cell-
autonomous effect fromSRF-deficientneurons.Toaddresswhether
SRF-deficient neurons contribute to the deficits in astrocytes ob-
served inSrf–Nestin–cKOmice,weanalyzedastrocytes inSrf–NEX–
cKO mice, in which SRF deletion was restricted to glutamatergic
neurons of the neocortex and hippocampus starting at approxi-
mately E11.5 (Lu and Ramanan, 2011). Immunostaining of P0.5
brains from Srf–NEX–cKOmice and control littermates using anti-
GFAP and anti-Aldh1L1 antibodies showed no differences in the
number of astrocytes localized in neocortex and hippocampus of
Srf–NEX–cKO mice compared with control littermates (Fig. 4A,B
and data not shown). Unlike the Srf–Nestin–cKOmutantmice, the
Srf–NEX–cKOmice donot exhibit neonatal lethality. Analyzing the
brains of 3-month-old Srf–NEX–cKOmice,we observednodeficits
in astrocytic numbers compared with control littermates (Fig.
4C,C). Together, these observations indicate that SRF plays a cell-
autonomous role within NPCs to promote astrocyte specification
both in vitro and in vivo and that SRF deletion in neurons does
not have any discernible effect on astrocyte specification and
maintenance.
Srf–Nestin–cKOmutant mice also exhibit a reduction in
oligodendrocyte precursors
SRF-deficient NPCs generated fewer astrocytes and oligodendro-
cytes during mitogen withdrawal in culture (Fig. 2E,F). We
askedwhether this also reflected a role for SRF in oligodendrocyte
specification in vivo. Oligodendrocytes are mostly generated in
the first few weeks after birth (Sauvageot and Stiles, 2002). How-
ever, OPCs can be seen in the brain as early as E10.5–E14.5
(Woodruff et al., 2001). Immunostaining for OPCs using Olig1
and Olig2 antibodies (Lu et al., 2000; Zhou et al., 2000) revealed
significantly (40–50%) fewer OPCs in multiple regions of Srf–
Nestin–cKO brains compared with wild-type control littermates
(Fig. 5A–D). These findings suggest that SRF is also critical for
oligodendrocyte specification in vivo.
Figure 5. SRF is critical for oligodendrocyte specification in vivo.A, OPCs in the brainwere identified by immunostaining for Olig2 expression in Srf–Nestin– cKO and controlmice at P0.5. Shown
here are neocortex, hippocampus, and striatum (n 3 mice). Scale bar, 50m. B, Quantification of Olig2 cells per area (in square micrometers) in A shows that the number of Olig2 OPCs is
reduced in Srf–Nestin– cKO mutants. C, Olig1 OPCs were also analyzed at P0.5 in control and Srf–Nestin– cKO brains. Shown here is the anterior corpus callosum and ventricular zone (vz). ctx,
Neocortex (n 3 mice). Scale bar, 50m. D, Quantification of Olig1 cells per area (square micrometers) in C also shows a significant reduction of OPC population in the mutant brain.
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SRF-deficient NPCs show impairment in oligodendrocyte
specification
Astrocytes have been shown to promote OPC survival in vitro by
the secretion of PDGF (Gard et al., 1995). Therefore, the reduced
OPCs observed in Srf–Nestin–cKO mutant brains could be at-
tributable to reduced astrocytes or this could reflect a cell-
autonomous role for SRF in oligodendrocyte specification.
PDGF, which promotes OPC proliferation (McKinnon et al.,
1990; Robinson and Miller, 1996), and T3, which drives oligo-
dendrocyte differentiation (Almazan et al., 1985), were supple-
mented to induce and enrich for differentiated oligodendrocytes.
We found that SRF-deficient NPCs generated twofold to three-
fold less PDGFR and Olig2OPCs at 2 d after induction and
similar deficits in APC/O4 and MBP differentiated oligo-
dendrocytes at 4 d after induction compared with wild-type
NPCs (Fig. 6A–D). We observed 0.5% of neurons and astro-
cytes under these pro-oligodendrocyte induction conditions
(data not shown). These findings recapitulate the in vivo obser-
vations made in Srf–Nestin–cKO brains and suggest that SRF
plays a cell-autonomous role in oligodendrocyte specification
and maturation.
Ectopic expression of SRF rescues both astrocyte and
oligodendrocyte specification in SRF-deficient NPCs
We asked whether the defects in astrocyte and oligodendro-
cyte specification observed in SRF-deficient NPCs reflects a
fundamental defect in differentiation in the absence of SRF
or whether these deficits suggest a requirement for SRF-
dependent transcription for glial cell-fate specification. NPCs
from Srf–Nestin– cKO and control littermates were trans-
duced with MSCV expressing either wild-type SRF (MSCV–
SRF) or empty vector (MSCV) alone. In control experiments
using the MSCV–SRF virus, we found nearly 98% transduc-
tion efficiency of SRF-deficient NPCs at 4 d after infection
using immunostaining for SRF (data not shown). We also
found that MSCV infection did not affect proliferation rates of
control and SRF-deficient NPCs (data not shown). Ectopic
expression of SRF alone in wild-type NPCs did not potentiate
glial differentiation (Fig. 7A–D). However, reintroduction of
SRF into SRF-deficient NPCs was sufficient to rescue the def-
icits in both astrocyte and oligodendrocyte differentiation in
the presence of CNTF/LIF and PDGF/T3, respectively, to the
levels seen in wild-type NPCs (Fig. 7A–D).
Figure 6. SRF-deficient NPCs show impairment in oligodendrocyte specification. A, Control and SRF-deficient NPCs were induced for oligodendrocyte lineage commitment using T3 (10 ng/ml)
and PDGF (2.5 ng/ml). At 2 DIV, OPCs were identified by Olig2 or PDGFR immunoreactivity. Scale bar, 25m. B, Quantification of PDGFR or Olig2 cells show that SRF-deficient NPCs
exhibit a reduced capacity for generating OPCs. C, At 4 DIV, differentiated oligodendrocyteswere identified fromAPC andO4 coexpression.Magnified images of colocalization of APC andO4 staining
are shown in C. Arrows point to late OPCs expressing O4 alone.Myelinatingmature oligodendrocytes identified byMBP expressionwere also reduced in SRF-deficient cultures (C). Scale bars: C, C,
25m; C, 10m. D, Cell count analysis demonstrates that, at 4 DIV, the number of differentiated oligodendrocytes is also significantly reduced in SRF-deficient NPC cultures.
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SRF is not sufficient to promote glial
differentiation but augments the effects
of astrocyte induction
Our findings thus far suggest that SRF is
required cell intrinsically to regulate glial
specification. We next asked whether ac-
tivation of SRF-dependent transcription
alone is sufficient to promote glial specifi-
cation. For this, we expressed constitu-
tively active SRF, SRF–VP16, a chimeric
protein generated by fusing the DNA
binding domain of SRF with the strong
transactivation domain of VP16 protein
from herpes simplex virus (Johansen and
Prywes, 1994; Schratt et al., 2002). SRF–
VP16 binds to target SRF binding ele-
ments (termed the CArG box sequence)
in the regulatory regions of its target genes
and activates gene expression even in the
absence of any stimuli that stimulate SRF-
dependent transcription. SRF-deficient
and control NPCs were transduced with
MSCV expressing either SRF–VP16 or
empty vector and were allowed to differ-
entiate after mitogen withdrawal. At 4 d
after mitogen withdrawal, we observed
that SRF–VP16 expression alone was not
sufficient to generate more astrocytes
compared with empty vector and even ex-
hibited an inhibitory effect on astrocyte
specification (Fig. 8A,B). However, when
NPCswere induced for astrocyte differen-
tiation by the addition of CNTF and LIF,
we found that SRF–VP16 significantly po-
tentiated astrocyte differentiation to a
similar extent in both control and SRF-
deficient NPCs (Fig. 8A,B).
Similarly, we also found that SRF–
VP16 was not sufficient to induce oligo-
dendrocyte differentiation in the absence
of mitogens (Fig. 8C,D). Interestingly, in
contrast to that observed for astrocytes,
expression of SRF–VP16 in NPCs inhib-
ited oligodendrocyte differentiation in the
presence of pro-oligodendrocyte factors
T3 and PDGF (Fig. 8C,D). A recent study showed that SRF–VP16
expression in neurons inhibited oligodendrocyte maturation
through a paracrine mechanism involving connective tissue
growth factor (CTGF) (Stritt et al., 2009).Our results suggest that
SRF–VP16 expression might exert a similar but an autocrine
inhibitory effect on NPCs to regulate oligodendrocyte differen-
tiation. In summary, our results identified SRF as a novel transcrip-
tional regulator critical but not sufficient for astrocyte and
oligodendrocyte differentiation in the brain.
Discussion
Astrocytes are the most abundant cell type in the mammalian
brain and perform critical roles in nearly every facet of brain
function, including synaptogenesis, neurotransmitter homeosta-
sis, and synaptic plasticity. Oligodendrocytes are responsible for
the generation and maintenance of myelination that facilitates
neuronal salutatory transmission as well as for providing trophic
support for the survival of neurons and growth of axons. In this
study, we found that mice with conditional deletion of SRF in
NPCs (Srf–Nestin–cKO) exhibit deficits in astrocytes and oligo-
dendrocyte specification in the brain. In contrast, SRF deletion in
neurons (Srf–NEX–cKO) does not affect astrocyte development,
suggesting a cell-autonomous role for SRF in astrocyte specifica-
tion. Cultured SRF-deficient NPCs do not display any defects in
proliferation or exhibit increased apoptosis. As observed in vivo,
SRF-deficient NPCs were unable to properly differentiate into
astrocytes and oligodendrocytes in response to lineage-specific
differentiation signals. Thus, our study identifies a previously
unknown cell-intrinsic role for SRF in glial cell-fate specification
in the brain.
SRF deletion in Srf–Nestin–cKO resulted in loss of40–60%
astrocytes and oligodendrocytes in vivo. The Srf–Nestin–cKO
mice also exhibited neonatal hemorrhage beginning at12–16 h
after birth and exhibited lethality soon after. The hemorrhagic
phenotype could be attributable to reduced astrocytes, which are
an essential component of the blood–brain barrier (Janzer and
Figure 7. Reintroduction of wild-type SRF rescues glial specification defects.A, Control and SRF-deficient NPCswere harvested
fromP0.5 brains andwere infectedwithMSCV–SRF orwithMSCV as control. NPCswere induced for astrocyte differentiation using
CNTF and LIF and immunostained for GFAP expression at 4 DIV. Scale bar, 25 m. B, Analysis of the percentage of astrocytes
generated shows that SRF expression rescues astrocyte differentiation in SRF-deficient NPCs but does not potentiate astrocyte
differentiation in control cells. C, Control and SRF-deficient NPCs were transduced with MSCV–SRF or MSCV and induced for
oligodendrocyte lineage using PDGF and T3. Arrows indicate APC and O4 differentiated oligodendrocytes, and arrowheads
point to O4 late OPCs (4 DIV). Scale bar, 25m.D, Quantification shows that SRF expression does not augment oligodendrocyte
differentiation in control NPCs but completely rescues differentiation deficits of SRF-deficient NPCs.
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Raff, 1987). Although not reported by several studies that have used
the Nestin–Cre transgenic mouse line used in this study, it is also
likely that there is leakyexpressionofCre recombinase inendothelial
cells. Because SRF has been shown to be important for vascular de-
velopment (Franco et al., 2008), SRF deletion in endothelial cells
could also compromise the integrity of the blood–brain barrier, re-
sulting in hemorrhage. Future work will determine whether the
hemorrhage is attributable to deficits in astrocyte numbers or vascu-
lar integrity or both.
Similar to the in vivo observations, SRF-deficient NPCs also
exhibited a failure to generate astrocytes and oligodendrocytes
when induced to differentiate in vitro. This could reflect a likely
delay in glial specification, which is difficult to assess in Srf–
Nestin–cKO mice because they exhibit neonatal lethality. How-
ever, we found that differentiation of SRF-deficientNPCs for longer
periods (until 12 d) in culture did not yield more astrocytes or oli-
godendrocytes, suggesting that a delay in specification is unlikely to
be the underlying cause of the glial deficits in Srf–Nestin–cKOmice
(our unpublished observations). Another possibility is that SRF is
required for specification of a particular
glial-restrictedprecursor cell subpopulation
or within a particular subpopulation for
glial differentiation. A population of glial-
restricted precursor cells that can generate
both astrocytes and oligodendrocytes ex-
press the surface antigen A2B5 (Rao and
Mayer-Proschel, 1997; Liu and Rao, 2004;
Lin and Goldman, 2009). Recent studies
have shown that astrocytes canbe generated
frommore thanoneprecursor cell type (Liu
et al., 2004; Lin and Goldman, 2009; Cai et
al., 2012). Future studies will aim to identify
these precursor subpopulations in the
brains of Srf–Nestin–cKO mice and study
their capacity to generate astrocyte and oli-
godendrocytes in the absence of SRF.
Recent observations have shown that
SRF-deficient neurons affect maturation of
oligodendrocyte precursors in a non-cell-
autonomous manner (Stritt et al., 2009). In
the reported Srf mutant mice, widespread
SRF loss in late-embryonic forebrain neu-
rons caused deficits in tangential neuronal
migration, leading to cell accumulation in
the subventricular zone (Alberti et al.,
2005). This led to massive apoptosis and
consequently triggered an increase in astro-
cytes postnatally possibly indicative of reac-
tive astrogliosis (Alberti et al., 2005; Stritt et
al., 2009). We found that SRF ablation in
developing glutamatergic neurons of the
neocortex and hippocampus in Srf–NEX–
cKO mice did not cause cell death or affect
astrocyte differentiation even at 3monthsof
age. However, SRF loss in NPCs alone
caused a significant reduction in astrocytes
both in vivo and in vitro. Therefore, neuro-
nal loss of SRF does not appear to have any
effect on astrocyte specification and
development.
Our findings suggest that SRF is re-
quired within NPCs to regulate oligoden-
drocyte specification. In addition,
expression of constitutively active SRF–VP16 in NPCs inhibited
oligodendrocyte specification in vitro. This observation is consis-
tent with recent findings in which SRF-deficient neurons were
shown to inhibit oligodendrocyte maturation in a paracrine
manner via secretion of CTGF (Stritt et al., 2009). This study also
showed that expression of SRF–VP16 in neurons inhibited mat-
uration of neighboring oligodendrocytes in vitro. SRF–VP16 has
not been shown to be subjected to the same regulatory mecha-
nisms that modulate endogenous SRF activity. Therefore, it is
likely that SRF–VP16 expression in NPCs also results in expres-
sion of CTGF, which could inhibit oligodendrocyte differentia-
tion in an autocrine manner.
Interestingly, SRF–VP16 appeared to have an inhibitory effect
on astrocyte specification in the absence of pro-astrocytic stimuli.
However, in contrast to that observed for oligodendrocyte differ-
entiation, SRF–VP16 expression resulted in 40% increase in
astrocyte differentiation in the presence of pro-astrocytic ligands.
One likely explanation is that SRF–VP16 results in the upregula-
tion of expression, withinNPCs, of receptors and/or intracellular
Figure8. Constitutively active SRF is insufficient for glial specification but potentiates ligand-induced astrocyte differentiation.
A, Control and SRF-deficient NPCs were transduced with either empty MSCV or MSCV–SRF–VP16 virus. Three days after viral
infection, NPCs were induced for astrocyte differentiation after mitogen withdrawal (representative images not shown) or with
CNTF and LIF. Scale bar, 50m. B, Quantification of GFAP astrocytes in A shows that, in the absence of mitogens, SRF–VP16
expression was slightly inhibitory to astrocyte specification. However, in the presence of LIF and CNTF, SRF–VP16 potentiated
astrocyte differentiation of both control and SRF-deficient NPCs (n 3). C, Oligodendrocyte differentiation of control and SRF-
deficient NPCs after infectionwith either emptyMSCVorMSCV–SRF–VP16 virus. NPCswere allowed to differentiate aftermitogen
withdrawal (representative images not shown) or were enriched for oligodendrocytes using T3 and PDGF. Differentiated oligo-
dendrocytes were identified by APC/O4 double immunoreactivity. Scale bar, 50 m. D, Quantification of C indicates that
SRF–VP16 is not sufficient to induce oligodendrocyte specification in the absence of pro-oligodendrocyte factors and inhibits
oligodendrocyte differentiation in the presence of T3 and PDGF (n 3).
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signaling proteins that are critical for astrocyte specification and
in the presence of appropriate extracellular stimuli this causes a
potentiated response and subsequent increase in astrocyte differ-
entiation. Future work will aim to identify the SRF target genes in
NPCs that are important for astrocyte and oligodendrocyte spec-
ification. Together, our observations strongly suggest that SRF
plays a cell-intrinsic role in NPCs to regulate astrocyte and oligo-
dendrocyte specification in the brain.
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